EE+ POEM Archive
Omalizumab at highest dose modestly effective for chronic idiopathic urticaria
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Omalizumab at Highest Dose Modestly Effective for Chronic Idiopathic Urticaria." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/427817/all/Omalizumab_at_highest_dose_modestly_effective_for_chronic_idiopathic_urticaria.
Omalizumab at highest dose modestly effective for chronic idiopathic urticaria. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427817/all/Omalizumab_at_highest_dose_modestly_effective_for_chronic_idiopathic_urticaria. Accessed October 15, 2024.
Omalizumab at highest dose modestly effective for chronic idiopathic urticaria. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427817/all/Omalizumab_at_highest_dose_modestly_effective_for_chronic_idiopathic_urticaria
Omalizumab at Highest Dose Modestly Effective for Chronic Idiopathic Urticaria [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 October 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427817/all/Omalizumab_at_highest_dose_modestly_effective_for_chronic_idiopathic_urticaria.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Omalizumab at highest dose modestly effective for chronic idiopathic urticaria
ID - 427817
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427817/all/Omalizumab_at_highest_dose_modestly_effective_for_chronic_idiopathic_urticaria
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
